tiprankstipranks
Fresh Tracks Therapeutics (FRTX)
OTHER OTC:FRTX
Holding FRTX?
Track your performance easily

Fresh Tracks Therapeutics (FRTX) Stock Price & Analysis

507 Followers

FRTX Stock Chart & Stats


Financials

Annual

Ownership Overview

42.00%<0.01%58.00%
42.00% Insiders
<0.01% Other Institutional Investors
58.00% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

FRTX FAQ

What was Fresh Tracks Therapeutics’s price range in the past 12 months?
Fresh Tracks Therapeutics lowest stock price was $0.55 and its highest was $1.03 in the past 12 months.
    What is Fresh Tracks Therapeutics’s market cap?
    Currently, no data Available
    When is Fresh Tracks Therapeutics’s upcoming earnings report date?
    Fresh Tracks Therapeutics’s upcoming earnings report date is Aug 08, 2024 which is 107 days ago.
      How were Fresh Tracks Therapeutics’s earnings last quarter?
      Currently, no data Available
      Is Fresh Tracks Therapeutics overvalued?
      According to Wall Street analysts Fresh Tracks Therapeutics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Fresh Tracks Therapeutics pay dividends?
        Fresh Tracks Therapeutics does not currently pay dividends.
        What is Fresh Tracks Therapeutics’s EPS estimate?
        Fresh Tracks Therapeutics’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Fresh Tracks Therapeutics have?
        Fresh Tracks Therapeutics has 5,973,306 shares outstanding.
          What happened to Fresh Tracks Therapeutics’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Fresh Tracks Therapeutics?
          Currently, no hedge funds are holding shares in FRTX
          ---

          Fresh Tracks Therapeutics Stock Smart Score

          Company Description

          Fresh Tracks Therapeutics

          Brickell Biotech, Inc. engages in the development of prescription therapeutics for the treatment of skin diseases. Its pipeline consists of new molecular entities targeting the treatment of the following indications: hyperhidrosis, allergic contact dermatitis, androgenic alopecia, cutaneous t-cell lymphoma and psoriasis. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in 2009 and is headquartered in Boulder, CO.
          ---

          FRTX Earnings Call

          Q3 2022
          0:00 / 0:00
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Eloxx Pharmaceuticals
          Mustang Bio
          Genprex
          Marinus
          Popular Stocks
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis